Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.
about
Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissueMolecular underpinnings of corneal angiogenesis: advances over the past decadeMatricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor CellsRemodelling the extracellular matrix in development and diseaseDevelopments in purification methods for obtaining and evaluation of collagen derived endogenous angioinhibitorsFamily Wide Molecular Adaptations to Underground Life in African Mole-Rats Revealed by Phylogenomic Analysis.Col4a1 mutations cause progressive retinal neovascular defects and retinopathyExtracellular Matrix, a Hard Player in AngiogenesisThe CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.FXR promotes endothelial cell motility through coordinated regulation of FAK and MMP-9.Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine.Inhibitory effects of arresten on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 activation in mouse retinal endothelial cellsExtracellular matrix modulates angiogenesis in physiological and pathological conditions.Pharmacoproteomic analysis of a novel cell-permeable peptide inhibitor of tumor-induced angiogenesis.Validation of Different Systems for Tumstatin Expression and its in-vitro and iv-vivo Activities.Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors.Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer.Multi-omic integrated networks connect DNA methylation and miRNA with skeletal muscle plasticity to chronic exercise in Type 2 diabetic obesity.Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma.T-CAM, a fastatin-FIII 9-10 fusion protein, potently enhances anti-angiogenic and anti-tumor activity via alphavbeta3 and alpha5beta1 integrins.Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosisThe role of type IV collagen and basement membranes in cancer progression and metastasis.Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.Molecular Cloning and Functional Characterization of Mouse α3(IV)NC1.Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular MatrixTumor stroma derived biomarkers in cancer.The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.L-arginine mediated renaturation enhances yield of human, α6 Type IV collagen non-collagenous domain from bacterial inclusion bodies.Integrin alpha1beta1 regulates matrix metalloproteinases via P38 mitogen-activated protein kinase in mesangial cells: implications for Alport syndrome.Detection of metals and metalloproteins in the plasma of stroke patients by mass spectrometry methodsCollagen Type IV and Laminin Expressions during Cartilage Repair and in Late Clinically Failed Repair Tissues from Human Subjects.Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.The extracellular matrix and blood vessel formation: not just a scaffold.Type IV collagen-derived angiogenesis inhibitorsIntegrin and growth factor receptor alliance in angiogenesis.Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the α6(IV)NC1 collagen fragment.FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IV)NC1
P2860
Q24670313-4E8C719A-2E57-487B-863E-5CB3E2158479Q26747539-54EF00FB-105A-4060-8971-80FF94A5B137Q26766481-E3ABF9B4-D54B-47CD-ACAD-25B78F39ED49Q26864798-B450A2A6-A57E-4B61-A0AE-ED1ECE86AF92Q27004391-9FB2F8F2-A4FB-49C6-86B5-FBCFF13E0F5EQ27300147-0ED8EAA4-3242-41A1-8D0C-70BA37FF8D97Q27303061-40224EB2-D56F-461D-8E76-C72CB9846472Q28072886-B4F58824-0BBD-4CC5-A781-DF8A9F8EC081Q30441368-7BFA1E11-F4AF-4FD1-AA51-689F1FFBABE3Q30488268-19703DF7-9E08-40D8-A1C9-30374DBD051AQ31058993-902216C6-21EA-42C5-B048-A1A2EADB7F02Q33685500-DCCA749E-18E6-4A9B-BCA9-0FE9276AC0DCQ33737210-E17D289A-0768-4168-B7C8-DFD0E3BF5A42Q33894448-87CE97C2-1313-4A7B-80F5-FDF56CDF9BBEQ34102845-915578FA-6072-4E6C-890E-225F6F0F2944Q34230899-63D0D5E7-4BF8-4C4A-96ED-F1E8FF6BEAE8Q34290867-A917FF67-D26B-4369-B59C-4E1BADC351D0Q34356389-D42D1A62-9ED8-4691-9FC0-A1D2D7B87852Q34507203-FDD73E25-4233-4EF7-A52C-A6A8E427E0E2Q34774929-C159AA86-4124-401C-9C84-6A885371C233Q35063753-B8734CC6-FAF0-40D7-A728-9B47C582D7EFQ35088047-A517EC15-B74D-4BF2-B2AE-0FA02FF64A51Q35175046-7600B347-A3A5-4591-9D92-3FDCF7B26A9EQ35180998-58E00B0D-1F4C-4A51-9200-976C186DCCA4Q35662667-10A321B4-105A-4078-8992-7D94E202AA42Q35679807-F269A4F1-B389-44A9-A7CA-B39521CFDB66Q35765454-52CB3C04-28DE-4A7B-820A-A5C4BFFE2027Q35856555-7FCBA680-CFDE-463E-A84B-1BDCBE3A5B18Q35925032-FEE3699B-9819-4471-A3B3-5F5BD61B0600Q36203315-1503CB13-0294-4204-AD80-2C90AD7442AEQ36482190-004224E0-44C0-4112-B417-72F5268C4AA8Q36539409-8C8A8D04-C564-40B9-9CE4-C9B9BFE9D99CQ36568912-BE7D2BE7-16A9-4DD4-B049-F645E33BEBEEQ36709721-4D564744-8C3C-4B95-AB2A-DED8CF51960AQ36815331-884D2F9F-676B-4E0F-AF4C-3FE21F648801Q36865710-8B59B57F-1B36-4A20-9112-E8BFCE09BEC5Q37339044-E33F625D-9E45-4E13-AF55-3AA5A0970A22Q37380604-8365B58D-CEE4-48AD-AC8F-57188FA76B84Q37401556-F321FB46-A62F-48F1-B9A1-D399601BCBECQ37482353-37092F4F-6DD9-4265-9B36-1EB54768678D
P2860
Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Human alpha1 type IV collagen ...... diated by alpha1beta1 integrin
@nl
Human alpha1 type IV collagen ...... iated by alpha1beta1 integrin.
@ast
Human alpha1 type IV collagen ...... iated by alpha1beta1 integrin.
@en
type
label
Human alpha1 type IV collagen ...... diated by alpha1beta1 integrin
@nl
Human alpha1 type IV collagen ...... iated by alpha1beta1 integrin.
@ast
Human alpha1 type IV collagen ...... iated by alpha1beta1 integrin.
@en
prefLabel
Human alpha1 type IV collagen ...... diated by alpha1beta1 integrin
@nl
Human alpha1 type IV collagen ...... iated by alpha1beta1 integrin.
@ast
Human alpha1 type IV collagen ...... iated by alpha1beta1 integrin.
@en
P2093
P2860
P356
P1476
Human alpha1 type IV collagen ...... iated by alpha1beta1 integrin.
@en
P2093
Akulapalli Sudhakar
Arjuna P Mannam
Dominic Cosgrove
Hikaru Sugimoto
Pia Nyberg
Raghu Kalluri
Venkateshwar G Keshamouni
P2860
P304
P356
10.1172/JCI24813
P407
P577
2005-09-08T00:00:00Z